Position in QTRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$105,096
New position
Shares Held
24,328
first reported quarter
Ownership
0.051%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#60
of 131 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Medical Devices
Healthcare · as of Jun 30, 2026Aigen Investment Management, LP holds $10,476,105 across 13 Medical Devices names. QTRX ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
49,551 | $4,496,257 | |
| 2 | MDT |
Medtronic plc
|
24,962 | $1,952,777 | |
| 3 | EW |
Edwards Lifesciences Corp
|
16,910 | $1,529,678 | |
| 4 | BSX |
Boston Scientific Corp
|
26,161 | $1,116,551 | |
| 5 | PODD |
Insulet Corp
|
3,046 | $463,753 | |
| 6 | HAE |
Haemonetics Corp
|
3,685 | $276,375 | |
| 7 | TMDX |
TransMedics Group, Inc.
|
3,821 | $253,790 | |
| 8 | QTRX |
Quanterix Corp
This page
|
24,328 | $105,096 |
All Filings in QTRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $105,096 | 24,328 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||